Showing 3901-3910 of 6035 results for "".
- AptarGroup Highlights New “Beat the Blink” Technologyhttps://modernod.com/news/aptargroup-highlights-new-beat-the-blink-technology/2485307/AptarGroup shared an overview of its portfolio of eye care solutions, including 'Beat the Blink,' a new eye care delivery system designed to improve dosing accuracy and enhance the patient experience by “beating the blink” reflex. The technology is currently part of
- Nanodropper Now Operating as Mu Medical Under New Consolidation Planhttps://modernod.com/news/nanodropper-now-operating-as-mu-medical-under-new-consolidation-plan/2485284/Nanodropper, provider of micro-volume ophthalmic delivery technology, announced that Bedo Solutions and Viseon Labs have agreed on terms to join its eyecare platform under a new corporate identity, Mu Medical. Financial terms of the deal were not disclosed.
- New International Myopia Guidance Urges Early, Personalized Carehttps://modernod.com/news/new-international-myopia-guidance-urges-early-personalized-care/2485288/The International Myopia Institute (IMI) has published its 2025 Digest, delivering the latest evidence-based guidance on myopia. The Dige
- Everest Medicines Expands into Ophthalmology with Licensing Agreement for Retinal Disease Candidate in Asiahttps://modernod.com/news/everest-medicines-expands-into-ophthalmology-with-licensing-agreement-for-retinal-disease-candidate-in-asia/2484302/Everest Medicines announced it has entered into an exclusive licensing agreement with Visara, a subsidiary of NovaBridge Biosciences to develop, manufacture, and commercialize VIS-101 in Greater China, Singapore, South Korea, and select Southeast Asian countri
- 4DMT and Otsuka Announce Strategic Partnership to Advance 4D-150 Gene Therapy Across Asia-Pacifichttps://modernod.com/news/4dmt-and-otsuka-announce-strategic-partnership-to-advance-4d-150-gene-therapy-across-asia-pacific/2484301/4D Molecular Therapeutics (4DMT) announced a strategic partnership with Otsuka Pharmaceutical to develop and commercialize 4D-150 for the treatment of wet age-related macular degeneration (AMD) and diabetic macular edema (DME) across the greater Asia-Pacific (
- Samsung Bioepis to Regain European Commercial Rights for Ophthalmology Biosimilars from Biogenhttps://modernod.com/news/samsung-bioepis-to-regain-european-commercial-rights-for-ophthalmology-biosimilars-from-biogen/2484299/Samsung Bioepis has entered into an Asset Purchase Agreement (APA) with Biogen concerning the transfer of two ophthalmology assets: Byooviz (ranibizumab) and Opuviz (aflibercept)—both biosimilars referencing leading treatments for retinal disea
- IDOC Unveils New Brand Identity and Platform for Optometristshttps://modernod.com/news/idoc-unveils-new-brand-identity-and-platform-for-optometrists/2484208/IDOC announced the launch of a refreshed brand identity and messaging platform designed to better serve independent optometrists. According to a news release, the revitalized brand aims to make independent ow
- Bausch + Lomb's Surgical Planning Software, Eyetelligence, Now Fully Commercially Available in UShttps://modernod.com/news/bausch-lombs-surgical-planning-software-eyetelligence-now-fully-commercially-available-in-us/2484204/Bausch + Lomb announced that its surgical planning software, Eyetelligence, is now available to all US ophthalmologists. Eyetelligence is designed to streamline a clinic’s operations and bring connectivity into the OR. According to B+L, the software helps surgeons make quick
- Topcon Healthcare Launches IDHea to Advance Digital Research in Eye Care and Oculomicshttps://modernod.com/news/topcon-healthcare-launches-idhea-to-advance-digital-research-in-eye-care-and-oculomics/2484202/Topcon Healthcare announced the launch of IDHea Inc., the Institute for Digital Health, a new company dedicated to transforming clinical research in eye care and the emerging field of oculomics—the study of ocular biomarkers that reflect systemic health.
- AAO: Office-Based Cataract Surgery Study Shows Success With Minimal Oral Sedationhttps://modernod.com/news/aao-office-based-cataract-surgery-study-shows-success-with-minimal-oral-sedation/2484197/A new study presented at the 129th annual meeting of the American Academy of Ophthalmology (AAO) is challenging long-held assumptions about cataract surgery. The research demonstrates that patients can safely and successfully undergo office-based cataract surgery u